Company intelligence / Profile preview
Precise Health
Epalinges, Vaud, Switzerlandprecisehealth.io ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Precise Health is developing a personalized, AI-driven bacteriophage therapy platform to replace broad-spectrum antibiotics, initially targeting inflammatory skin diseases such as acne and atopic dermatitis. The company is preparing animal studies for bacterial sepsis. No clinical results have been published yet; the company remains preclinical with market launch preparations underway.
- Therapeutic areas
- DermatologyInfectious Diseases
- Modalities
- Bacteriophage therapyBiologic
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Precise Health.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Precise Health.